Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-effectiveness analysis of empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-Reduced trial.
Tsutsui H, Sakamaki H, Momomura SI, Sakata Y, Kotobuki Y, Linden S, Reifsnider OS, Rakonczai P, Stargardter M, Murata T, Hirase T, Nitta D. Tsutsui H, et al. Among authors: kotobuki y. J Cardiol. 2023 Jun;81(6):522-530. doi: 10.1016/j.jjcc.2023.02.007. Epub 2023 Feb 28. J Cardiol. 2023. PMID: 36858174 Free article.
Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium-glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes.
Yabe D, Shiki K, Suzaki K, Meinicke T, Kotobuki Y, Nishida K, Clark D, Yasui A, Seino Y. Yabe D, et al. Among authors: kotobuki y. BMJ Open. 2021 Apr 7;11(4):e045844. doi: 10.1136/bmjopen-2020-045844. BMJ Open. 2021. PMID: 33827843 Free PMC article. Clinical Trial.
Exacerbation of livedoid vasculopathy after coronavirus disease 2019.
Kawabe R, Tonomura K, Kotobuki Y, Ueda-Hayakawa I, Murota H, Fujimoto M. Kawabe R, et al. Among authors: kotobuki y. Eur J Dermatol. 2022 Jan 1;32(1):129-131. doi: 10.1684/ejd.2022.4200. Eur J Dermatol. 2022. PMID: 35653093 Free PMC article. No abstract available.
Corrigendum to "Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies" [J. Autoimmun. 126 (2022) 102774].
Arase N, Tsuji H, Takamatsu H, Jin H, Konaka H, Hamaguchi Y, Tonomura K, Kotobuki Y, Ueda-Hayakawa I, Matsuoka S, Hirano T, Yorifuji H, Murota H, Ohmura K, Nakashima R, Sato T, Kumanogoh A, Katayama I, Arase H, Fujimoto M. Arase N, et al. Among authors: kotobuki y. J Autoimmun. 2022 Feb;127:102797. doi: 10.1016/j.jaut.2022.102797. Epub 2022 Feb 9. J Autoimmun. 2022. PMID: 35148921 Free article. No abstract available.
Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies.
Arase N, Tsuji H, Takamatsu H, Jin H, Konaka H, Hamaguchi Y, Tonomura K, Kotobuki Y, Ueda-Hayakawa I, Matsuoka S, Hirano T, Yorifuji H, Murota H, Ohmura K, Nakashima R, Sato T, Kumanogoh A, Katayama I, Arase H, Fujimoto M. Arase N, et al. Among authors: kotobuki y. J Autoimmun. 2022 Jan;126:102774. doi: 10.1016/j.jaut.2021.102774. Epub 2021 Dec 9. J Autoimmun. 2022. PMID: 34896887 Free article.
43 results